{'fraction_non_alphanumeric': 0.040268456375838924, 'fraction_numerical': 0.026845637583892617, 'mean_word_length': 4.97, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Treatment-resistant depressions in borderline psychiatry].

UNLABELLED
We studied the efficacy of venlafaxine in treatment-resistant depressions of the borderline level. Thirty patients, aged from 23 to 63 years, with non-psychotic depressions were examined. Due to the absence of the effect of the previous treatment, they were treated with venlafaxine in dosage 75-150 mg/day during 35 weeks. The positive response was seen in 19 (63,7%) patients. The drug was well-tolerated.


IN CONCLUSION
venlafaxine may be used as an affective medication in treatment-resistant non-psychotic depressions.